NCT01300104

Brief Summary

PURPOSE: To evaluate the feasibility of a future Nordic intervention trial, including vigorous activity and a high intake of whole grain rye, among prostate cancer patients on active surveillance. Additionally, to investigate effects of the lifestyle intervention according to cancer progression, the metabolic profile, inflammation and quality of life among prostate cancer patients on active surveillance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable prostate-cancer

Timeline
Completed

Started Feb 2011

Typical duration for not_applicable prostate-cancer

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
17 days until next milestone

First Submitted

Initial submission to the registry

February 18, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 21, 2011

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

February 19, 2015

Status Verified

February 1, 2015

Enrollment Period

4 years

First QC Date

February 18, 2011

Last Update Submit

February 18, 2015

Conditions

Keywords

prostate cancer progressionactive surveillancewhole grain ryeexerciseinsulin sensitivityquality of life

Outcome Measures

Primary Outcomes (1)

  • Feasibility of a planned Nordic life style intervention

    Feasibility of an intervention trial is evaluated among Danish men with early stage prostate cancer. Enrollment of participants, possible for this particular type of trial among the particular patient group? Compliance with intervention, obtainable for intervention participants with the tools planned (counseling sessions, exercise programs, supply of rye products, sphygmographs and pedometers)? Does the design minimize drop out? Is the schedule for monitoring, counseling, testing and collection of biological samples efficient and feasible for the research team and for the participants?

    Five years

Secondary Outcomes (5)

  • Prostate cancer progression, effect of the life style intervention

    One year

  • Insulin sensitivity and insulin secretion, effect of the life style intervention

    One year

  • Life quality, effect of the life style intervention

    One year

  • Metabolic profile, effect of the life style intervention

    One year

  • Inflammation, effect of the life style intervention

    One year

Study Arms (2)

Exercise and whole grain rye

EXPERIMENTAL
Behavioral: ExerciseBehavioral: Whole grain ryeBehavioral: Recommendations

No prescriptions

ACTIVE COMPARATOR
Behavioral: Recommendations

Interventions

ExerciseBEHAVIORAL

Prescriptions: Vigorous exercise (average 65-70% of maximal oxygen consumption) minimum 3 times 45 minutes per week according to customized endurance training programs. Restrictions: None.

Exercise and whole grain rye
Whole grain ryeBEHAVIORAL

Prescriptions: Minimum 170-180g of whole grain rye intake per day. Restrictions: None.

Exercise and whole grain rye
RecommendationsBEHAVIORAL

Recommendations on a health-promoting, energy restricted diet according to Danish Nutrition Recommendations and encouraged to walk at least 10,000 steps every day.

Exercise and whole grain ryeNo prescriptions

Eligibility Criteria

Age55 Years - 70 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Biopsy proven prostate cancer within 2 years prior to enrolment
  • PSA ≤ 10 ng/ml, Gleason-score ≤ 6, clinical localized prostate cancer ≤ cT2a or PSA ≤ 10 ng/ml, Gleason-score ≤ 7, clinical localized prostate cancer ≤ cT2a.
  • Maximum 1/5 tumor positive biopsy rate
  • On active surveillance (elected to forgo treatment)
  • Level of testosterone normal in sera

You may not qualify if:

  • Prior history of cancer, except for non-melanoma skin cancer, unless considered cured without signs of treatment failure for at least five years
  • Less than 10 years of life expectancy
  • Conditions or behaviors likely to affect the capability of participating fully in the intervention
  • Moderate to severe co-morbidity (kidney, liver, heart or respiratory problems) or the general physical constitution
  • Gluten intolerance
  • Inflammatory bowel disease (e.g. Crohn, colitis)
  • Physical handicaps

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Aarhus University, Institute of Sport Science

Aarhus, 8000, Denmark

Location

Counseling Center, Danish Cancer Society

Aarhus, 8000, Denmark

Location

Aarhus University Hospital Skejby

Aarhus, 8200, Denmark

Location

Danish Cancer Society

Copenhagen, 2100, Denmark

Location

Related Publications (1)

  • Eriksen AK, Hansen RD, Borre M, Larsen RG, Jensen JM, Overgaard K, Borre M, Kyro C, Landberg R, Olsen A, Tjonneland A. A lifestyle intervention among elderly men on active surveillance for non-aggressive prostate cancer: a randomised feasibility study with whole-grain rye and exercise. Trials. 2017 Jan 13;18(1):20. doi: 10.1186/s13063-016-1734-1.

MeSH Terms

Conditions

Prostatic NeoplasmsMotor ActivityInsulin Resistance

Interventions

ExerciseHealth Planning Guidelines

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital DiseasesBehaviorHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaHealth PlanningHealth Care Economics and Organizations

Study Officials

  • Anne Tjønneland, Dr.Med.Sci.

    Danish Cancer Society Research Center

    STUDY DIRECTOR
  • Rikke D Hansen, Dr.

    Danish Cancer Society Research Center

    PRINCIPAL INVESTIGATOR
  • Michael Borre, Prof.

    Aarhus University Hospital Skejby

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator / Project Manager

Study Record Dates

First Submitted

February 18, 2011

First Posted

February 21, 2011

Study Start

February 1, 2011

Primary Completion

February 1, 2015

Study Completion

February 1, 2015

Last Updated

February 19, 2015

Record last verified: 2015-02

Locations